Malaysia Launches Unified Plan to Fight Cancer, TB & Respiratory Diseases

Kuala Lumpur – Malaysia is implementing a new national strategy to address a trio of significant public health challenges: cancer, tuberculosis (TB), and chronic respiratory diseases. The unified approach, recently detailed in The Lancet, aims to streamline resources and improve outcomes across these interconnected areas of lung health.

Early Screening Reveals TB Prevalence

A key component of this initiative, the Lung Health Initiative (LHI), has already yielded some notable early findings. According to reports from November 2025, initial screenings of approximately 3,000 individuals have detected a significantly higher number of TB cases than lung cancer cases. This was somewhat unexpected, as the program utilizes AI-assisted X-ray technology designed to identify abnormalities indicative of all three target conditions. Dr. Mat Zuki Mat Jaeb, National Head of the Respiratory Subspecialty at the Ministry of Health, explained that the AI doesn’t solely flag potential cancer nodules; it as well identifies signs of infection, fibrosis, and other lung issues. This broader diagnostic capability allows for the early detection of diseases even in patients who are not yet experiencing symptoms.

The discovery of a high proportion of mild, asymptomatic TB cases is being viewed as a positive development. Traditionally, hospitals in Malaysia have primarily seen more severe, advanced cases of pulmonary TB. The LHI’s ability to identify TB at an earlier stage, before symptoms become pronounced, offers the potential for more effective treatment and reduced transmission. The program aims to reduce deaths from TB, chronic obstructive pulmonary disease (COPD), and lung cancer by 30% within five years.

Rising TB Cases in Malaysia: A Broader Context

The findings from the LHI align with a broader trend of increasing TB cases in Malaysia. Recent data indicates a 5.5% rise in cases in 2023, reaching 26,781, and an additional 10% increase in early 2026. The Straits Times reports that several factors are contributing to this resurgence, including declining immunity levels, delays in detection, and increasing drug resistance due to poor treatment compliance. TB spreads through prolonged close contact, making crowded environments – such as those often seen during events like Ramadan bazaars – potential hotspots for transmission.

One case highlighted in The Straits Times illustrates the challenges of latent TB infection. Mr. Hisyam Mohamad, a 42-year-classic oil palm smallholder, was diagnosed with TB in 2023 after experiencing significant weight loss, persistent cough, and shortness of breath. He had previously been exposed to TB through his father-in-law years earlier, but had been told he carried a “sleeping” or latent infection. This underscores the importance of recognizing that TB bacteria can remain dormant in the body for years, potentially reactivating when immunity is compromised.

Understanding Latent TB Infection

Latent TB infection means a person has been infected with the TB bacteria, but the immune system is keeping the bacteria from growing and causing illness. People with latent TB infection do not feel sick and cannot spread the infection to others. However, if the immune system weakens, the bacteria can become active, leading to TB disease. Treatment for latent TB infection can prevent the development of active TB disease.

The Integrated Approach: Beyond Detection

The Malaysian government’s new national plan represents a shift towards a more integrated approach to lung health. Traditionally, cancer, TB, and chronic respiratory diseases have been addressed through separate programs and initiatives. By combining these efforts, the Ministry of Health hopes to achieve greater efficiency and impact. The LHI’s use of AI-assisted X-rays is a prime example of this innovation, allowing for a broader range of lung conditions to be screened for simultaneously.

The program’s success hinges on effective referral pathways. When abnormalities are detected through screening, patients are referred for further evaluation and, if necessary, treatment. This requires strong coordination between primary care providers, specialists, and public health authorities. The involvement of organizations like the World Health Organization (WHO) and Pace University Center for Global Health, as noted during the “Unpacking the Chronic Respiratory Disease Epidemic” media workshop, suggests a commitment to international collaboration and best practices.

What Comes Next: Surveillance and Guidance Updates

The Ministry of Health will continue to monitor the results of the LHI closely, analyzing data on screening rates, detection rates, and treatment outcomes. This ongoing surveillance will inform adjustments to the program as needed. Further research is also likely to be conducted to better understand the factors driving the rise in TB cases in Malaysia and to identify effective strategies for prevention and control. Public health guidance regarding TB prevention, including recommendations for vaccination (where available) and infection control measures, will be regularly reviewed and updated based on the latest evidence. Individuals concerned about potential TB exposure should consult with a qualified healthcare professional for appropriate evaluation and guidance.